Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$552,593
-$269,480 QoQ
Shares Held
125,305
-3.1% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. NAGE ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in NAGE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $552,593 | 125,305 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $822,073 | 129,257 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,190,432 | 127,592 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,038,830 | 72,091 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $772,261 | 111,922 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $587,375 | 110,617 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $732,772 | 200,760 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $544,921 | 199,605 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $643,890 | 185,026 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $170,229 | 119,042 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $123,506 | 84,594 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $133,364 | 84,946 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $128,657 | 84,090 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $141,538 | 84,249 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $93,043 | 75,645 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $7,084 | 2,880 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,836 | 10,117 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $34,371 | 5,482 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,640 | 3,209 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $29,234 | 3,130 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $16,204 | 3,376 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $104 | 26 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $380 | 83 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $694 | 213 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||